Results 41 to 50 of about 272,686 (351)
Frontiers in Physiology, 2021 Adjustments in renal K+ excretion constitute a central mechanism for K+ homeostasis. The renal outer medullary potassium (ROMK) channel accounts for the major K+ secretory route in collecting ducts during basal conditions.
Juliano Zequini Polidoro +2 more
doaj +1 more source
AT1AA (Angiotensin II Type-1 Receptor Autoantibodies).
HYPERTENSION, 2019 AT1AA (Angiotensin II type-1 receptor autoantibodies) were first detected in patients with primary aldosteronism (PA) because of aldosterone-producing adenoma (APA) with an in-house developed assay, but it remained unclear if they can be ascertained also
M. Piazza +7 more
semanticscholar +1 more source
Jurnal Urologi Indonesia, 2016 Objective: The aim of the study was to detect the differences in number and the distribution of angiotensin II type-1 receptor (AT1R) in BPH, high grade PIN, and adenocarcinoma of the prostate. Material & method: A prospective study was performed in RSHS,
Isdianto Septiadi +11 more
doaj +1 more source
Angiotensin II type 1 receptor expression in human pancreatic cancer and growth inhibition by angiotensin II type 1 receptor antagonist [PDF]
FEBS Letters, 2001 We investigated the expression of angiotensin II type 1 receptor (AT1) in pancreatic cancer. Both AT1 mRNA and protein were expressed in human pancreatic cancer tissues and cell lines. Binding assays showed that pancreatic cancer cells have specific binding sites for angiotensin II and that binding could be eliminated by treatment with a selective AT1 ...
Fujimoto, Yoshifumi +3 more
openaire +2 more sources
American Journal of Transplantation, 2013 Reports have associated non‐HLA antibodies, specifically those against angiotensin II type‐1 receptor (AT1R), with antibody‐mediated kidney graft rejection. However, association of anti‐AT1R with graft failure had not been demonstrated.
M. Taniguchi +12 more
semanticscholar +1 more source
The potential therapeutic use of renin-angiotensin system inhibitors in the treatment of inflammatory diseases [PDF]
, 2019 Inflammation is a normal part of the immune response to injury or infection but its dysregulation promotes the development of inflammatory diseases, which cause considerable human suffering.
Avan, Amir +5 more
core +1 more source
Angiotensin II type 1 receptor antagonists and their combinations in the treatment of hypertension
South African Family Practice, 2012 No abstract available.
J.A. Ker
doaj +1 more source
Physiological Reports, 2021 Cognitive impairment has been known as a common consequence of brain inflammation. Long‐term potentiation (LTP), the generally accepted cellular mechanism for memory formation in the mammalian brain, has been shown to be suppressed by inflammation ...
Mahmoud Hosseini +2 more
doaj +1 more source
Bortezomib-containing multimodality treatment for antibody-mediated rejection with anti-HLA and anti-AT1R antibodies after kidney transplantation [PDF]
, 2017 For decades, the human leukocyte antigen (HLA) complex has been considered the primary target of antibody-mediated rejection (AMR), and treatment strategies have mainly focused on anti-HLA antibodies.
Favi, Evaldo +3 more
core +1 more source
Increase of angiotensin II type 1 receptor auto-antibodies in Huntington’s disease [PDF]
, 2014 Background In the recent years, a role of the immune system in Huntington’s disease (HD) is increasingly recognized. Here we investigate the presence of T cell activating auto-antibodies against angiotensin II type 1 receptors (AT1R) in all stages of the
Dechend, Ralf +15 more
core +3 more sources